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MyOCarDIal revasCUlarIzatIOn                                 
In aCUte COrOnary synDrOMe                                              
In UDMUrt repUblIC
Kuzmina N.M.
The urgency of the investigated problem is caused by high mortality from 
cardiovascular diseases. The aim of the study is to evaluate the results of 
myocardial revascularization in acute coronary syndrome. In the study of this 
problem, theoretical and empirical methods are applied: analysis of literature, 
study and generalization of innovative medical experience, analysis, synthesis, 
observation. 
Materials and methods. We studied retrospectively 125 case histories 
of patients who entered the Republican Clinical Diagnostic Center in 2015 
with the diagnosis of acute coronary syndrome (ACS) for percutaneous cor-
onary intervention (PCI) and treated in the department of acute myocardial 
infarction No.1. All patients underwent PCI. These patients have a stent in 
the coronary artery. The 95 patients were admitted to the control echocardi-
ography 1.8–2 years after PCI. The data was analyzed using the Microsoft 
Excel program. 
Results. Basically there is a rescue or prepared PCI in our republic. 
In 77% of patients, the pathological wave Q / QS was formed at the time 
of admission. The left ventricle ejection fraction was higher and the num-
ber of nonfunctional zones of myocardium was lower in patients who had 
undergone PCI later. The echocardiography results are improving with an 
increase of the time from onset of the disease to percutaneous coronary 
interventions. 
Conclusions. It is shown that at the time of reoxygenation the formation of 
reactive oxygen species sharply increases and can damage the cell. This arti-
cle can be useful for cardiologists, intervention surgeons, therapists, medical 
students, interns, postgraduate students.
Keywords: ischemic heart disease; acute coronary syndrome; myocardial 
infarction; unstable angina; percutaneous coronary interventions; lipid per-
oxidation.
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РеваскуляРизация миокаРда                                  
пРи остРом коРонаРном синдРоме                 
в удмуРтской Республике
Кузьмина Н.М.
Актуальность изучаемой проблемы обусловлена высокой смертно-
стью от сердечно-сосудистых заболеваний. Целью работы является 
оценка результатов реваскуляризации миокарда при остром коронарном 
синдроме. 
Материалы и методы. Ретроспективно было изучено 125 историй 
болезни пациентов, поступивших с острым коронарным синдромом в 
отделение острого инфаркта миокарда №1 БУЗ УР «Республиканского 
клинико-диагностического центра МЗ УР». Всем пациентам проведено 
чрескожное коронарное вмешательство (ЧКВ), установлен стент в ко-
ронарную артерию. 95 пациентам была проведена контрольная эхокар-
диогарфия спустя 1,8–2 года после ЧКВ. Данные были проанализирова-
ны при помощи программы Microsoft Excel. 
Результаты. В основном в Удмуртии в 2015 году проводилось спаси-
тельное или отсроченное ЧКВ. У 77% пациентов к моменту поступле-
ния сформировался патологический зубец Q/QS. Фракция выброса боль-
ше, количество афункциональных зон меньше у пациентов с большим 
временем от начала клиники до ЧКВ.
Выводы. Это говорит о том, что возможно во время реоксигенации 
активируется перекисное окисление липидов и свободные радикалы повре-
ждают клетки. Данная статья может быть полезна врачам-кардиоло-
гам, терапевтам, интервенционным хирургам, ординаторам, аспирантам.
Ключевые слова: ишемическая болезнь сердца; острый коронарный 
синдром; инфаркт миокарда; нестабильная стенокардия; чрескожное 
коронарное вмешательство; перекисное окисление липидов.
1. Introduction
1.1. Relevance
Ischemic heart disease (IHD) is a socially significant disease. IHD is char-
acterized by a high prevalence among the population, a recurring course of the 
disease, repeated and prolonged inpatient treatment. Exacerbation of IHD is an 
acute coronary syndrome. Acute coronary syndrome (ACS) is one of the most 
frequent causes of hospitalization of patients.
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1.2. Literature Review 
1.2.1 Atheroslerosis
Worldwide, coronary artery disease (CAD) is the most frequent cause of 
death. Over seven million people die from CAD every year, accounting for 
12.8% of all deaths. Every sixth man and every seventh woman in Europe will 
die from myocardial infarction [1, p. 733].
ACS refers to any group of clinical signs or symptoms that allow suspect-
ed acute myocardial infarction (MI) or unstable angina (UA). With ACS, the 
likelihood of developing myocardial infarction with all its consequences (ar-
rhythmias, heart failure) increases, and the high death rate of patients remains 
significant [2, p. 825].
It is considered that the cause of IHD is atherosclerosis of the heart vessels. 
The most significant complications of the atherosclerotic process are:
1. A hemodynamically significant narrowing of the artery lumen due to an 
atherosclerotic plaque protruding into the lumen of the artery (Fig. 1).
2. Destruction of the fibrous capsule, its ulceration, platelet aggregation 
and the genesis of a parietal thrombus (Fig. 1).
3. The rupture of the fibrous capsule of the atherosclerotic plaque and the 
loss of the contents of the detritus lipid core into the lumen of the ves-
sel. The detritus lipid core can become a source of embolism or the for-
mation of a parietal thrombus.
4. Hemorrhage into the plaque from newly formed microvessels. It also 
can contributes to the rupture of plaque cover and the formation of a 
thrombus on the surface of the atherosclerotic plaque.
5. The deposition of calcium salts in atheromatous masses, interstitial sub-
stance and fibrous tissue, it significantly increase the density of athero-
sclerotic plaque [3, p. 13].
Fig. 1. Atherosclerotic plaque
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1.2.2 Percutaneous coronary interventions 
The fight against IHD is very active now. The goal is to save the lives of 
patients. Progress in this field is associated with the development of high-tech 
medical care in acute coronary syndrome in the form of percutaneous coronary 
interventions (PCI) (Fig. 2) [4, p. 1598].
Fig. 2. PCI
Types of PCI:
– Primary PCI is defined as an emergent percutaneous catheter inter-
vention in the setting of ACS, without previous fibrinolytic treatment. 
Lower mortality rates among patients undergoing primary PCI are ob-
served in centres with a high volume of PCI procedures. Primary PCI 
is effective in securing and maintaining coronary artery patency and 
avoids some of the bleeding risks of fibrinolysis [5, p. 19]; [6, p. 13]; 
[7, p. 2686]; 
– Rescue PCI is an intervention performed in a symptom-responsible 
artery that remains occluded after the administration of thrombolytic 
agents. In settings where primary PCI cannot be performed within 120 
min of FMC by an experienced team, fibrinolysis should be considered, 
particularly if it can be given pre-hospital (e.g. in the ambulance) and 
within the first 120 min of symptom onset [8, p. 2512]; [9, p. 429]; [10, 
p. 2851]. It should be followed by consideration of rescue PCI or rou-
tine angiography [11, p. 94].
– Prepared (“facilitated”) PCI is a planned intervention within 12 hours of 
the development of symptoms of MI, occurring shortly after the use of 
fibrinolytic agents and / or platelet IIb / IIIa receptor blockers [12, p. 156].
The logistics algorithm for acute myocardial infarction is represented in 
Figure 3.
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Fig. 3. Prehospital and in-hospital management and reperfusion strategies within 24 h  
of FMC (adapted from Wijns et al.) [13, p. 2501]; [19, p. 15].
1.2.3. Lipid peroxidation
At the same time, the complex problem of atherosclerosis cannot be re-
duced to the level of cholesterol and lipoproteins in the blood. In recent years, 
the literature discusses the role of lipid peroxidation (LPO) in the etiology and 
pathogenesis of atherosclerosis. 
Indeed, the membranes of cells and subcellular organelles, as well as 
blood plasma lipoproteins contain phospholipids. There are polyunsaturated 
fatty acids (PUFAs) are localized.in the b-position of phospholipids. PUFAs 
are readily subjected to free radical peroxide oxidation in the presence of 
oxygen with formation of corresponding lipid peroxides [14, p. 1413]; [15, 
p. 305]; [16, p. 299].
39В мире научных открытий, Том 9, №4, 2017
Active forms of oxygen damage the structure of DNA, proteins and var-
ious membrane structures of cells [17, p. 127]. As a result of the appear-
ance of hydrophilic zones in the hydrophobic layer due to the formation of 
hydroperoxides of fatty acids water, sodium, calcium ions can penetrate 
into the cells, which leads to the swelling of cells, organelles and their 
destruction[18, p. 257]; [19, p. 340]. Peroxide oxidation is also activat-
ed in tissues that underwent first ischemia and then reoxygenation, which 
occurs in spasm of the coronary arteries and their subsequent expansion 
[9, p. 429].
2. Materials and Methods
2.1. The aim
The aim of the study is to evaluate the results of myocardial revasculariza-
tion in acute coronary syndrome.
2.2 Research objectives
The research objectives are: 1) to see the time of PCI; 2) to сonsider the 
structure of ACS; 3) to study the age of patients; 4) to study the kinds of the 
lesion of the coronary arteries; 4) to study the parameters of echocardiography.
2.3. Hypothesis
Hypothesis. Early revascularization in the first minutes of ACS does not al-
ways have a positive effect on the myocardium, the contractile function of the 
myocardium decreases.
2.4. Inclusion criteria: the presence of ACS, the absence of previously 
transferred coronary artery bypass grafting (CABG) or stenting of the coro-
nary arteries (CA).
2.5. Exclusion criteria: previous CABG or CA stenting, active tuberculo-
sis, prisoners, incompetent persons.
2.6. Proсess of the study
We studied retrospectively 155 case histories of patients who entered the 
Republican Clinical Diagnostic Center in 2015 with the diagnosis of acute 
coronary syndrome (ACS) for percutaneous coronary intervention (PCI) and 
treated in the department of acute myocardial infarction No.1. The data was 
analyzed using the Microsoft Excel program.
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All patients underwent PCI. These patients have a stent in the coronary 
artery. Patients were admitted to the control echocardiography 1.8–2 years 
after PCI.
3. results
With unstable angina was received 22 patients, with acute myocardial in-
farction-133 patients. 
Age averaged 59 years ± 10.62 (min-34 years, max-88 years, mode-66 
years). The body mass index (BMI) is on average-27.02 ± 2.87 (mode-25.71).
The time from the onset of pain to the “balloon” in 32 patients was 1–6 
hours, 11 patients-6–12 hours, 112 patients-more than 12 hours.
In 77% of patients, pathological wave Q / QS was formed.
Thrombolytic therapy was performed in 27% of cases at the prehospital stage.
Lesion of the left main coronary artery was in 42 patients (stenoses within 
15–80%), in 14 patients (9%) stenoses reached 50–80%.
Stenoses of more than 75% in the proximal segment of the anterior inter-
ventricular artery was identified in 64 patients (41%), in the middle section – in 
61 patients (39%), in the distal segment – in 17 patients (11%).
Stenoses of more than 75% in the proximal segment of the left circumflex 
coronary artery artery was identified in 28 patients (38%), in the middle sec-
tion – in 13 patients (18%), in the distal segment – in 32 patients (44%).
Stenoses of more than 75% in the proximal segment of the right coronary 
artery artery was identified in 26 patients (25%), in the middle section – in 59 
patients (58%), in the distal segment – in 17 patients (17%).
All patients underwent stenting of the infarct-dependent coronary artery. 
The protocols of echocardiography are analyzed. The left ventricle ejection 
fraction (LVEF) averaged 55.98 ± 7.81% (min-28%, max-73%), the final di-
astolic volume of the left ventricle (LV) was 139.82 ± 29.33 ml (min-74 ml, 
max-313 ml).
Interrelationships were revealed (Pirson coefficient):
– a direct statistically significant relationship between the time from on-
set of the disease to the “balloon” and the left ventricle ejection fraction 
(r = 0.3, p <0.05);
– a direct statistically significant relationship between the time from on-
set of the disease to the “balloon” and the number of zones with region-
al wall-motion abnormalities of the LV (r = -0.18, p <0.05);
– inverse correlative statistically significant relationship between lesion 
of the left main coronary artery and LVEF (r = -0.16, p <0.05);
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– a direct correlation statistically significant relationship between the body 
mass index and lesion of the left main coronary artery (r = 0.24, p <0.05).
Identified by the Spearman rank correlation coefficient:
– a inverse statistically significant relationship between the time from on-
set of the disease to the “balloon” and the left ventricle ejection fraction 
after 1.8-2 years from PCI (rs = -0.331, p<0.01);
– a inverse statistically significant relationship between the time from on-
set of the disease to the “balloon” and the left ventricle end-diastolic 
volume after 1.8-2 years from PCI (rs = -0.17, p<0.05);
– a inverse statistically significant relationship between the time from on-
set of the disease to the “balloon” and the right ventricle end-diastolic 
volume after 1.8–2 years from PCI (rs = -0.583, p<0.01).
4. Discussion
An overwhelming number of patients were admitted to the PCI laboratory 
at 12 hours or more from the onset of symptoms. Basically, there is a rescue or 
prepared PCI. In 77% of patients, the pathological wave Q / QS was formed 
at the time of admission. The left ventricle ejection fraction was higher and 
the number of nonfunctional zones of myocardium was lower in patients who 
had undergone PCI later. The echocardiography results are improving with an 
increase of the time from onset of the disease to PCI. Patients with a longer 
pain-balloon time had a lower end-diastolic LV volume, a smaller right ven-
tricular cavity in the diastole, a smaller LV ejection fraction due to reduced 
end-diastolic LV volume and a hypo / akinesia zone after 1.8–2 years from PCI.
5. Conclusions
The formation of a thrombus leads to the occlusion of the lumen of the 
vessel and the development of ischemia in the corresponding part of the myo-
cardium (tissue hypoxia). If rapid medical measures are taken to destroy the 
thrombus, oxygen supply (reoxygenation) is restored in the tissue. It is shown 
that at the time of reoxygenation the formation of reactive oxygen species 
sharply increases and can damage the cell. Thus, despite the rapid restoration 
of blood circulation cells are damaged at the corresponding site of the myocar-
dium by the activation of peroxidation.
6. recommendations
This article can be useful for cardiologists, intervention surgeons, thera-
pists, medical students, interns, postgraduate students.
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